A female patient was treated with high-dose inhaled fluticasone propionate
for her asthma, Over 2 years, she developed features of Gushing's syndrome
with proximal myopathy, osteopenia, hypertension, depressive psychosis, and
cushingoid appearance. She had biochemical evidence of marked adrenal supp
ression with a 9:00 AM serum cortisol of 20 nmol/L that returned to normal
(315 mol/L) after her therapy was changed to budenoside, 0.8 mg/d, Her appe
arance, mental state, and myopathy also improved with no loss of asthma con
trol. This case illustrates the potential for developing clinically relevan
t adverse effects of inhaled corticosteroids when given at licensed doses.